COVID-19 / Coronavirus
111 Signs Strategic Cooperation Agreement with Jianming Pharmaceutical to Develop Chronic Disease Management Platform
2021-03-25 17:00
2285
SHANGHAI, March 25, 2021 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (Nasdaq: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, and Jianming Pharmaceutical Group ("Jianming Pharmaceutical"), a p...
No COVID slump as majority of Australians satisfied with healthcare system new Australian Healthcare Index reports
2021-03-25 03:00
1581
MELBOURNE and PERTH, Australia, March 25, 2021 /PRNewswire/ -- Despite a once-in-a-century pandemic still lingering one year on, Australians have given a vote of confidence to the Australian healthcare system with 65.5% rating it a score of 8 or above out of 10 in a new report, produced by the Au...
Adults with obesity treated with semaglutide 2.4 mg achieved and maintained a significant amount of weight loss in a 68-week trial
2021-03-24 04:41
1318
Data presented at ENDO 2021 demonstrate clinically relevant weight loss, without weight regain, in people treated with semaglutide 2.4 mg vs placebo in combination with lifestyle intervention. BAGSVÆRD, Denmark, March 24, 2021 /PRNewswire/ -- New results from the STEP phase 3a clinical trial p...
RDIF: Sputnik V approved in Vietnam
2021-03-23 20:45
2242
MOSCOW, March 23, 2021 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces the approval of the Russian Sputnik V vaccine against coronavirus by the Ministry of Health of the Socialist Republic ofVietnam. Thus Sputnik V is now approved for use in 56...
Ortho's VITROS® SARS-CoV-2 Antigen Test for High-Volume Testing Receives FDA Emergency Use Authorization for New Performance, Sensitivity Data
2021-03-23 20:00
2829
RARITAN, N.J., March 23, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced it received authorization from the U.S. Food and Drug Administration to update key claims for the VITROS® SARS-CoV-2 Antige...
CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine Convidecia™ in Hungary
2021-03-23 00:43
3623
* Marks vaccine's first approval by an European Union member state, following Mexico, Pakistan and China * Continues to boost production capacity to meet increasing demand * Safe, stable storage and transportation between 2°C and 8°C, accessible by under-developed regions * 95.47% effectiv...
Eucure Biopharma Announces Breakthrough Phase I Results for Anti-CTLA-4 Therapy in Combination with Junshi Biosciences' Anti-PD-1
2021-03-22 22:30
1823
BOSTON and BEIJING, March 22, 2021 /PRNewswire/ -- Eucure Biopharma, a subsidiary of Biocytogen focused on developing proprietary immuno-oncology antibodies, announced that its anti-CTLA-4 antibody (YH001), in combination with Junshi Biosciences' anti-PD-1 monoclonal antibody, Toripalimab Injecti...
PathogenDx Applauded by Frost & Sullivan for Its Ultra-rapid COVID-19 Testing Platform, DetectX-Rv Test
2021-03-22 22:00
1552
PathogenDx's disruptive nucleic acid-based test uses a multiplex microarray to rapidly identify, detect, and quantify multiple pathogens and viral strains SANTA CLARA, Calif., March 22, 2021 /PRNewswire/ -- Based on its recent analysis of the global molecular testing market,Frost & Sullivan recog...
Xylonix Reveals New Drug Compound for Combating Cancer and Abnormal Macrophages
2021-03-22 21:00
1616
SINGAPORE, March 22, 2021 /PRNewswire/ -- Xylonix, a Singapore-based biotech company, has developed a new immunity drug (010DS-Zn) that demonstrates potential for treating a variety of solid cancers and COVID-19's post-recovery complications, which include heart damage, diabetes and multi-system ...
Xylonix Reveals New Drug Compound for Combating Cancer and Abnormal Macrophages
2021-03-22 21:00
1350
SINGAPORE, March 22, 2021 /PRNewswire/ -- Xylonix, a Singapore-based biotech company, has developed a new immunity drug (010DS-Zn) that demonstrates potential for treating a variety of solid cancers and COVID-19's post-recovery complications, which include heart damage, diabetes and multi-system ...
RedHill Biopharma Announces Compassionate Use Treatment with Opaganib of first COVID-19 Patients in Switzerland
2021-03-22 19:00
3038
TEL AVIV, Israel and RALEIGH, N.C., March 22, 2021 /PRNewswire/ -- RedHill
Biopharma Ltd.
Airly raises $3.3m from marquee tech investors to address the air quality health crisis
2021-03-22 09:00
3729
- Problem: More than 10 million people die each year from air pollution - Solution: Airly's sensors and software provide ultra-local, accurate, predictive air quality data to help control air pollution across the world - Traction: Revenue increased over 200% outside the home market in 2020 with ...
Notice to the Extraordinary General Meeting of Elekta AB (publ)
2021-03-19 21:30
5588
STOCKHOLM, March 19, 2021 /PRNewswire/ -- Shareholders of Elekta AB (publ), reg. no. 556170-4015, are hereby invited to attend the Extraordinary General Meeting to be held on Friday16 April 2021. Due to the coronavirus pandemic, the Board of Directors has decided that the Meeting should be condu...
Samsung Biologics Unveils Strong Performance and Future Plans at its 10th Annual General Meeting of Shareholders
2021-03-19 09:49
4696
INCHEON, South Korea, March 18, 2021 /PRNewswire/ -- Samsung Biologics (KRX:
207940.KS) announced a strong year in 2020 as it reported1 trillion won in
target sales within just a decade at its 10th Annual General Meeting (AGM) on
March 19th Korea time.
MGI Contributes to Africa's COVID-19 Response Efforts
2021-03-18 22:02
2289
SHENZHEN, China, March 18, 2021 /PRNewswire/ -- MGI
'Global Fully Charged' sector moving towards a sustainable future: By Kalkine Pty Limited
2021-03-18 06:00
1444
SYDNEY, March 18, 2021 /PRNewswire/ -- With more focus on an 'Electrified World', and policymakers paving way for a sustainable future, 'Battery-Storage Technologies' Space seems to be the next wave of a frenzy to mitigate climate-change. 'The role of batteries in enabling a 'Global Green Econom...
Merck Accelerates European Expansion Plans for Single-use Products Critical to Manufacturing Vaccines and Lifesaving Therapies
2021-03-17 23:40
2671
DARMSTADT, Germany, March 17, 2021 /PRNewswire/ -- Merck, a leading science and technology company, will add a single-use assembly production unit at its Life Science Center in Molsheim,France. With the € 25 million investment, the company is accelerating its European expansion plans for this key...
"Shareholders would be Best Served by Electing [Chul Whan Park] to the Company's Board of Directors at This Time"
2021-03-17 22:40
1740
* "Park's proposals present a mid-to-long-term plan with improved dividend policy and capacity for future investments to enhance long-term corporate value." * "Park could continue to advocate for the various strategic, financial and governance reforms he believes are necessary in order to enh...
New Data Demonstrates Nu.Q® is Effective in Monitoring Treatment of Sepsis
2021-03-17 20:00
5193
AUSTIN, Texas, March 17, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, has been working ...
Biobohemia Released Paper on the Discovery of the Antigenic Essence of Cancer Cells
2021-03-17 20:00
1401
BOSTON, March 17, 2021 /PRNewswire/ -- Scientists announced today that they have discovered why they have not succeeded in developing a vaccine against cancer. Vaccination is a powerful tool that has helped us cope with many dangerous diseases, and it is an effective means of combatting the curre...
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 275 media titles]
2024-04-23 15:43INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 273 media titles]
2024-04-24 17:09Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00Most Read
TCTM Filed 2023 Annual Report on Form 20-F
2024-04-20 05:48
3322
Dingdong Files Its Annual Report on Form 20-F
2024-04-20 05:00
3069